Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × NIH × Malaria × Clear all

Phase

Phase 1 2 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 34 Melanoma 32 Brain Neoplasms 30 Gliosarcoma 29 Breast Neoplasms 27 Lymphoma 23 Neoplasm Metastasis 21 Astrocytoma 20 Carcinoma, Non-Small-Cell Lung 19 Leukemia 18 Neoplasms 17 Leukemia, Myeloid, Acute 17 Colonic Neoplasms 17 Central Nervous System Neoplasms 17 Prostatic Neoplasms 16 Colorectal Neoplasms 16 Rectal Neoplasms 15 Multiple Myeloma 15 Carcinoma, Renal Cell 15 Squamous Cell Carcinoma of Head and Neck 14 Lymphoma, Large B-Cell, Diffuse 14 Precursor Cell Lymphoblastic Leukemia-Lymphoma 13 Oligodendroglioma 13 Lymphoma, Non-Hodgkin 13 Sarcoma 12 Pancreatic Neoplasms 12 Myelodysplastic Syndromes 12 Lung Neoplasms 12 Leukemia, Lymphocytic, Chronic, B-Cell 12 Hodgkin Disease 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00341250 2017-07-02

Malaria Vaccine in Children in Mali

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed

Burkitt Lymphoma, Malaria

Data powered by HemOnc (CC BY 4.0) Colophon ⚡